Log in

NASDAQ:ATRI - Atrion Stock Price, Forecast & News

$717.93
-3.07 (-0.43 %)
(As of 01/29/2020 01:23 AM ET)
Today's Range
$717.93
Now: $717.93
$728.24
50-Day Range
$684.80
MA: $723.29
$757.60
52-Week Range
$675.34
Now: $717.93
$948.03
Volume5,091 shs
Average Volume6,463 shs
Market Capitalization$1.33 billion
P/E Ratio36.69
Dividend Yield0.86%
Beta0.15
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$152.45 million
Cash Flow$23.35 per share
Book Value$113.76 per share

Profitability

Net Income$34.26 million

Miscellaneous

Employees570
Market Cap$1.33 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.


Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Tuesday, November 12th. Shareholders of record on Monday, December 2nd will be paid a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 annualized dividend and a yield of 0.86%. The ex-dividend date is Friday, November 29th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a net margin of 23.43% and a return on equity of 16.45%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion.

Has Atrion been receiving favorable news coverage?

News articles about ATRI stock have trended extremely negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Atrion earned a media sentiment score of -4.3 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Atrion.

Are investors shorting Atrion?

Atrion saw a drop in short interest in December. As of December 31st, there was short interest totalling 101,500 shares, a drop of 7.6% from the December 15th total of 109,800 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is presently 9.7 days. Currently, 7.1% of the shares of the stock are short sold. View Atrion's Current Options Chain.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include ABM Industries (ABM), International Paper (IP), AT&T (T), Westrock (WRK), Exxon Mobil (XOM), Gilead Sciences (GILD), Methanex (MEOH), Pattern Energy Group (PEGI), Walgreens Boots Alliance (WBA) and AbbVie (ABBV).

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.01%), Pennsylvania Trust Co (0.56%), California Public Employees Retirement System (0.19%), Virginia Retirement Systems ET AL (0.09%), Hudson Valley Investment Advisors Inc. ADV (0.05%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, California Public Employees Retirement System, Nisa Investment Advisors LLC, Virginia Retirement Systems ET AL and Pennsylvania Trust Co. Company insiders that have sold Atrion company stock in the last year include John P Stupp Jr and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.

Which institutional investors are buying Atrion stock?

ATRI stock was purchased by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp and Hudson Valley Investment Advisors Inc. ADV. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $717.93.

How big of a company is Atrion?

Atrion has a market capitalization of $1.33 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion.

What is Atrion's official website?

The official website for Atrion is http://www.atrioncorp.com/.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel